Physician profile
James Radke
NPI 1518953025
$1,050.90
in general payments reported to CMS, 2019-2025
19 companies · $438 in 2025
The $438 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.81 · 2023: $442 · 2024: $155 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,013 · Education: $22.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,012.93 |
| Education | $22.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $302.11 | 2023-2025 | |
| Janssen Biotech, INC. | $129.13 | 2023-2025 | Simponi Aria, Stelara, Simponi |
| Ardelyx, INC. | $101.32 | 2025 | Ibsrela |
| Amgen INC. | $60.13 | 2023-2024 | Evenity, Prolia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.46 | 2023-2025 | Xifaxan |
| Novo Nordisk INC | $53.89 | 2023-2025 | Wegovy, Saxenda |
| Takeda Pharmaceuticals U.S.A., INC. | $49.29 | 2021-2024 | Entyvio, Gattex |
| Madrigal Pharmaceuticals | $47.03 | 2025 | Rezdiffra |
| Celgene Corporation | $36.90 | 2023 | Zeposia |
| Bayer Healthcare Pharmaceuticals INC. | $31.49 | 2023 | |
| Braintree Laboratories, INC. | $31.40 | 2025 | Suflave, Sutab |
| Gilead Sciences, INC. | $29.73 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $22.16 | 2023 | Dupixent |
| Aimmune Therapeutics, INC. | $18.45 | 2025 | Zenpep |
| Intercept Pharmaceuticals, INC. | $17.93 | 2023 | Ocaliva |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $16.97 | 2023 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.60 | 2024 | |
| Exact Sciences Corporation | $14.99 | 2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $13.92 | 2024 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Radke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.